The Effect of the Interaction of Sleep Onset Latency and Age on Ischemic Stroke Severity Via Inflammatory Chemokines

Overview

Journal Front Neurol

Specialty Neurology

Date 2024 Mar 4

PMID 38434201

Authors

Yuyu Zhou

Xiaoli Han

Qingshuang Mu

Lifei Xing

Yan Wu

Cunbao Li

Yanlong Liu

Fan Wang

Affiliations

Soon will be listed here.

Abstract

Objective: Prolonged sleep onset latency (PSOL) and age have been linked to ischemic stroke (IS) severity and the production of chemokines and inflammation, both of which contribute to IS development. This study aimed to explore the relationship between chemokines, inflammation, and the interplay between sleep onset latency (SOL) and age in influencing stroke severity.

Methods: A cohort of 281 participants with mild to moderate IS was enrolled. Stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS), and SOL was recorded. Serum levels of macrophage inflammatory protein-1alpha (MIP-1α), macrophage inflammatory protein-1beta (MIP-1β), monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) were measured.

Results: NIHSS scores of middle-aged participants with PSOL were significantly higher than those with normal sleep onset latency (NSOL) ( = 0.046). This difference was also observed when compared to both the elderly with NSOL ( = 0.022), and PSOL ( < 0.001). Among middle-aged adults with PSOL, MIP-1β exhibited a protective effect on NIHSS scores (β = -0.01, = -2.11, = 0.039, = 0.13). MIP-1α demonstrated a protective effect on NIHSS scores in the elderly with NSOL (β = -0.03, = -2.27, = 0.027, = 0.12).

Conclusion: This study reveals a hitherto undocumented association between PSOL and IS severity, along with the potential protective effects of MIP-1β in mitigating stroke severity, especially among middle-aged patients.

References

Reddin C, Murphy R, Hankey G, Judge C, Xavier D, Rosengren A . Association of Psychosocial Stress With Risk of Acute Stroke. JAMA Netw Open. 2022; 5(12):e2244836. PMC: 9856236. DOI: 10.1001/jamanetworkopen.2022.44836. View

Hawes N, Wiggins A, Reed D, Hardin-Fanning F . Poor sleep quality is associated with obesity and depression in farmers. Public Health Nurs. 2019; 36(3):270-275. DOI: 10.1111/phn.12587. View

Chen R, Balami J, Esiri M, Chen L, Buchan A . Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol. 2010; 6(5):256-65. DOI: 10.1038/nrneurol.2010.36. View

Mai X, Liang X . Risk Factors for Stroke Based on the National Health and Nutrition Examination Survey. J Nutr Health Aging. 2020; 24(7):791-795. DOI: 10.1007/s12603-020-1430-4. View

Porcher L, Bruckmeier S, Burbano S, Finnell J, Gorny N, Klett J . Aging triggers an upregulation of a multitude of cytokines in the male and especially the female rodent hippocampus but more discrete changes in other brain regions. J Neuroinflammation. 2021; 18(1):219. PMC: 8459490. DOI: 10.1186/s12974-021-02252-6. View

Sieber M, Claus R, Witte O, Frahm C . Attenuated inflammatory response in aged mice brains following stroke. PLoS One. 2011; 6(10):e26288. PMC: 3196544. DOI: 10.1371/journal.pone.0026288. View

Kasner S . Clinical interpretation and use of stroke scales. Lancet Neurol. 2006; 5(7):603-12. DOI: 10.1016/S1474-4422(06)70495-1. View

Milrad S, Hall D, Jutagir D, Lattie E, Ironson G, Wohlgemuth W . Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women. J Neuroimmunol. 2017; 303:43-50. PMC: 5258835. DOI: 10.1016/j.jneuroim.2016.12.008. View

Finger C, Moreno-Gonzalez I, Gutierrez A, Moruno-Manchon J, McCullough L . Age-related immune alterations and cerebrovascular inflammation. Mol Psychiatry. 2021; 27(2):803-818. PMC: 9046462. DOI: 10.1038/s41380-021-01361-1. View

10.

Hofmeijer J, van Kaam R, Vermeer S, van Putten M . Severely Disturbed Sleep in Patients With Acute Ischemic Stroke on Stroke Units: A Pilot Study. Front Neurol. 2019; 10:1109. PMC: 6824098. DOI: 10.3389/fneur.2019.01109. View

11.

Song Y, Zhang X, Li C, Xu S, Zhou B, Wu X . Is Bilirubin Associated with the Severity of Ischemic Stroke? A Dose Response Meta-Analysis. J Clin Med. 2022; 11(12). PMC: 9224549. DOI: 10.3390/jcm11123262. View

12.

Scinicariello F, Buser M, Feroe A, Attanasio R . Antimony and sleep-related disorders: NHANES 2005-2008. Environ Res. 2017; 156:247-252. PMC: 5685481. DOI: 10.1016/j.envres.2017.03.036. View

13.

Zhang Y, Xia X, Zhang T, Zhang C, Liu R, Yang Y . Relationship between sleep disorders and the prognosis of neurological function after stroke. Front Neurol. 2022; 13:1036980. PMC: 9659634. DOI: 10.3389/fneur.2022.1036980. View

14.

Huang Y, Chen S, Luo Y, Han Z . Crosstalk between Inflammation and the BBB in Stroke. Curr Neuropharmacol. 2020; 18(12):1227-1236. PMC: 7770647. DOI: 10.2174/1570159X18666200620230321. View

15.

Kadier K, Qin L, Ainiwaer A, Rehemuding R, Dilixiati D, Du Y . Association of sleep-related disorders with cardiovascular disease among adults in the United States: A cross-sectional study based on national health and nutrition examination survey 2005-2008. Front Cardiovasc Med. 2022; 9:954238. PMC: 9386143. DOI: 10.3389/fcvm.2022.954238. View

16.

Mander B, Winer J, Walker M . Sleep and Human Aging. Neuron. 2017; 94(1):19-36. PMC: 5810920. DOI: 10.1016/j.neuron.2017.02.004. View

17.

Aigner A, Grittner U, Rolfs A, Norrving B, Siegerink B, Busch M . Contribution of Established Stroke Risk Factors to the Burden of Stroke in Young Adults. Stroke. 2017; 48(7):1744-1751. DOI: 10.1161/STROKEAHA.117.016599. View

18.

Reinholdsson M, Palstam A, Sunnerhagen K . Prestroke physical activity could influence acute stroke severity (part of PAPSIGOT). Neurology. 2018; 91(16):e1461-e1467. PMC: 6202943. DOI: 10.1212/WNL.0000000000006354. View

19.

Jones K, Maguire J, Davenport A . Chemokine receptor CCR5: from AIDS to atherosclerosis. Br J Pharmacol. 2010; 162(7):1453-69. PMC: 3057285. DOI: 10.1111/j.1476-5381.2010.01147.x. View

20.

Lindley R, Wardlaw J, Whiteley W, Cohen G, Blackwell L, Murray G . Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial. Stroke. 2015; 46(3):746-56. DOI: 10.1161/STROKEAHA.114.006573. View